Clinical trials
Completed Phase 3 Hemorrhage trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
92 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 5 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 92 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ethicon, Inc. | 5 |
| Astellas Pharma Inc | 4 |
| Boehringer Ingelheim | 4 |
| AO GENERIUM | 3 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Hamilton Health Sciences Corporation | 2 |
| Jason Sperry | 2 |
| London School of Hygiene and Tropical Medicine | 2 |
| Portola Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhage | 92 |
| Venous Thromboembolism | 6 |
| Thrombosis | 5 |
| Atrial Fibrillation | 4 |
| Purpura, Thrombocytopenic, Idiopathic | 4 |
| Shock, Hemorrhagic | 4 |
| Venous Thrombosis | 4 |
| Hemostatic Disorders | 3 |
| Pulmonary Embolism | 3 |
| Thrombocytopenia | 3 |
Trials
Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.